Press coverage about Tekla Healthcare Investors (NYSE:HQH) has trended somewhat positive recently, Accern Sentiment reports. The research firm rates the sentiment of news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Tekla Healthcare Investors earned a news impact score of 0.23 on Accern’s scale. Accern also assigned news articles about the financial services provider an impact score of 45.9452359472512 out of 100, indicating that recent news coverage is somewhat unlikely to have an impact on the stock’s share price in the immediate future.

Tekla Healthcare Investors (HQH) opened at 24.83 on Thursday. Tekla Healthcare Investors has a 12 month low of $19.92 and a 12 month high of $26.37. The stock’s 50 day moving average price is $25.10 and its 200-day moving average price is $24.65.

The business also recently declared a quarterly dividend, which will be paid on Friday, September 29th. Stockholders of record on Monday, August 28th will be paid a dividend of $0.51 per share. This represents a $2.04 annualized dividend and a dividend yield of 8.22%. The ex-dividend date is Thursday, August 24th. This is an increase from Tekla Healthcare Investors’s previous quarterly dividend of $0.50.

ILLEGAL ACTIVITY WARNING: “Somewhat Favorable News Coverage Somewhat Unlikely to Impact Tekla Healthcare Investors (HQH) Share Price” was first reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this report on another publication, it was copied illegally and reposted in violation of United States & international copyright law. The legal version of this report can be viewed at https://www.thecerbatgem.com/2017/08/31/somewhat-favorable-news-coverage-somewhat-unlikely-to-impact-tekla-healthcare-investors-hqh-share-price.html.

Tekla Healthcare Investors Company Profile

Tekla Healthcare Investors is a non-diversified closed-end healthcare fund. The Fund’s investment objective is to seek long-term capital appreciation by investing primarily in securities of healthcare companies. It seeks to provide regular distribution of realized capital gains. It may invest up to 20% of its net assets in securities of foreign issuers, located primarily in Western Europe, Canada and Japan, and securities of United States issuers that are traded in foreign markets.

Insider Buying and Selling by Quarter for Tekla Healthcare Investors (NYSE:HQH)

Receive News & Stock Ratings for Tekla Healthcare Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tekla Healthcare Investors and related stocks with our FREE daily email newsletter.